Skip to main content

Use of Metoclopramide among Patients with Diabetic Gastroparesis and Type 2 Diabetes

Basic Details
Date Posted
Status
Complete
Medical Product
metoclopramide HCL
Health Outcome(s)
duration of use
Description

The goal of this query was to examine utilization of metoclopramide among female members without evidence of liveborn delivery with type 2 diabetes. We also examined female members without evidence of liveborn delivery with a combination of type 2 diabetes and diabetic gastroparesis in the Sentinel Distributed Database (SDD). Data from January 1, 2008 - September 30, 2015 from 17 Data Partners who contributed to the SDD were included in this report. This request was distributed on May 24, 2018.

Deliverables (1)
Sentinel Modular Program Report: Use of Metoclopramide among Patients with Diabetic Gastroparesis and Type 2 Diabetes
Additional Details
FDA Center
CDER
Time Period
January 1, 2008 - September 30, 2015
Analysis Type
Descriptive
Population / Cohort
Females 40 years of age and older
Data Sources
Sentinel Distributed Database (SDD)
Related Links
Sentinel Drug Assessment: Gimoti (Metoclopramide) & Duration of Use